| Photodynamic therapy in cancer treatment-an update review AF dos Santos, DRQ de Almeida, LF Terra, MS Baptista, L Labriola J. Cancer Metastasis Treat 5 (25), 10.20517, 2019 | 447 | 2019 |
| Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead SJ Oiseth, MS Aziz J Cancer Metastasis Treat 3 (10), 250-261, 2017 | 420 | 2017 |
| Function of cancer cell-derived extracellular matrix in tumor progression GF Xiong, R Xu J. Cancer Metastasis Treat 2 (9), 357, 2016 | 142 | 2016 |
| Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgery Y Yagawa, K Tanigawa, Y Kobayashi, M Yamamoto J. Cancer Metastasis Treat 3 (10), 218, 2017 | 123 | 2017 |
| Therapeutic strategies targeting cancer stem cells X Ning, J Shu, Y Du, Q Ben, Z Li Cancer biology & therapy 14 (4), 295-303, 2013 | 118 | 2013 |
| ESR1 alterations and metastasis in estrogen receptor positive breast cancer JT Lei, X Gou, S Seker, MJ Ellis Journal of cancer metastasis and treatment 5, 2019 | 106 | 2019 |
| Targeting the JAK/STAT pathway in solid tumors Z Qureshy, DE Johnson, JR Grandis Journal of cancer metastasis and treatment 6, 2020 | 101 | 2020 |
| DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression W Wang, AM Mani, ZH Wu Journal of cancer metastasis and treatment 3, 45, 2017 | 93 | 2017 |
| Role of circulating tumor cells in future diagnosis and therapy of cancer PD Potdar, NK Lotey J. Cancer Metastasis Treat 1 (2), 44, 2015 | 75 | 2015 |
| The role of human papillomaviruses in cancer progression P Tulay, N Serakinci J Cancer Metastasis Treat 2 (6), 201, 2016 | 68 | 2016 |
| TGF-β stimulation of EMT programs elicits non-genomic ER-α activity and anti-estrogen resistance in breast cancer cells M Tian, WP Schiemann Journal of cancer metastasis and treatment 3, 150, 2017 | 56 | 2017 |
| The systemic hallmarks of cancer D Paul J. Cancer Metastasis Treat 6 (10.20517), 2394-4722.2020, 2020 | 54 | 2020 |
| Electrolyte disorders in cancer patients: a systematic review R Berardi, M Torniai, E Lenci, F Pecci, F Morgese, S Rinaldi J Cancer Metastasis Treat 5 (79), 1-33, 2019 | 53 | 2019 |
| Metabolic alterations and the potential for targeting metabolic pathways in the treatment of multiple myeloma D Rizzieri, B Paul, Y Kang Journal of cancer metastasis and treatment 5, 2019 | 53 | 2019 |
| Growth factor receptors: promising drug targets in cancer S Tiash, EH Chowdhury J. Cancer Metastasis Treat 1, 190-200, 2015 | 53 | 2015 |
| The role of the PI3K/AKT/mTOR pathway in brain tumor metastasis S Crespo, M Kind, A Arcaro J Cancer Metastasis Treat 2 (3), 80-89, 2016 | 49 | 2016 |
| Autophagy in breast cancer metastatic dormancy: Tumor suppressing or tumor promoting functions? ALB Flynn, WP Schiemann Journal of cancer metastasis and treatment 5, 2019 | 43 | 2019 |
| Seaweeds’ nutraceutical and biomedical potential in cancer therapy: A concise review J Cotas, D Pacheco, AMM Gonçalves, P Silva, LG Carvalho, L Pereira Journal of cancer metastasis and treatment 7, 13, 2021 | 41 | 2021 |
| Nanocarrier drugs in the treatment of brain tumors T Cerna, M Stiborova, V Adam, R Kizek, T Eckschlager J. Cancer Metastasis Treat 2, 407-416, 2016 | 41 | 2016 |
| Targeting Toll-like receptors against cancer B Du, QL Jiang, J Cleveland, BR Liu, D Zhang Journal of Cancer Metastasis and Treatment 2 (12), 2016, 2016 | 38 | 2016 |
